NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Luxendo Boosts InVi SPIM Capabilities for 'Pure Life Imaging' - Enhanced Light-Sheet Fluorescence Microscopy Enables Long-Term Observation of Living Cells - Luxendo.eu
Luxendo Boosts InVi SPIM Capabilities for 'Pure Life Imaging'

 

NewswireTODAY - /newswire/ - Heidelberg, Germany, 2018/03/27 - Enhanced Light-Sheet Fluorescence Microscopy Enables Long-Term Observation of Living Cells - Luxendo.eu. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Luxendo, a Bruker company, today announced the extension of the InVi SPIM microscope to include full incubation capabilities, as well as flexible illumination and detection optics. Luxendo’s proprietary single-plane illumination microscopy (SPIM) technique significantly reduces sampling times over conventional laser scanning confocal microscopes, while reducing phototoxicity and damaging side effects on living specimens. The new technology also enables the fastest scan speeds for volumetric imaging of small organisms, cell monolayers, and cleared tissue. InVi SPIM combines these capabilities with perfect environmental conditions and gentle sample handling to create an optimized platform for ‘pure life imaging‘.

"We have been using the InVi SPIM light-sheet microscope to image breast tumor organoids derived from primary mammary epithelial cells,” said Dr. Martin Jechlinger, Group Leader for the Cell Biology and Biophysics Unit, EMBL Heidelberg, Germany, and EMBL Rome. “Ease of mounting the sample has allowed us to acquire fantastic images of tumor progression and regression on the InVi. Now, with its full incubation functionality and its improved illumination and detection concept, we can run long-term experiments on tumorigenesis that are not feasible on any other microscope system.”

“In live-cell imaging, the effect of photons to the specimen can have a big impact on the cells’ viability and unabridged development,” said Dr. Andreas Pfuhl, Managing Director of Luxendo. “With the inverted InVi SPIM platform combining precise environmental control with highly flexible optical settings, we can ensure that the observation method is not interfering with the cells’ physiological behavior.”

The InVi SPIM’s successful handling of extremely sensitive specimens, such as embryonic cells during their first divisions, has been proven in recent publications (Strnad et al., Nature Methods 2015; Reichmann et al., Science 2018). Other samples, such as tumor spheroids, organoids, and all kinds of culture cell lines, can now be imaged with more than 80 frames per second in full frame 2048 x 2048-pixel resolution up to 500 frames per second in 192 x 2048 resolution.

About InVi SPIM

The InVi SPIM microscope enables fast 3D imaging with extremely gentle sample handling for cell cultures and developing embryonic samples. Easy access to the sample chamber, maximized photo-efficiency, and short illumination times enable long-term imaging without harming live specimens. Simultaneous dual-channel detection allows the observation of multiple fluorophores without compromising acquisition speed. At the same time, the light-sheet length and thickness can be adapted to the two available magnification steps. While the specimen is kept in a specific sample carrier that serves as a “curved coverslip,” the environmental control is thoroughly monitored and adjusted for humidity, temperature, carbon dioxide and oxygen concentration. This stabilizes the experimental conditions in cellular imaging in such a way that observation times for up to 72 hours can be achieved.

About Luxendo

Headquartered in Heidelberg, Germany, Luxendo (luxendo.eu) was founded in September 2015 as a spin-off of the European Molecular Biology Laboratory (EMBL). Under the technical leadership of Dr. Lars Hufnagel, Luxendo was able to rapidly develop robust product solutions based on the patented SPIM technology. Now, as part of Bruker Corporation, Luxendo’s light-sheet microscopes join Bruker’s existing portfolio of swept-field confocal, super-resolution, and multiphoton fluorescence microscope product lines, enabling new research advances in small organism embryology, live-cell imaging, brain development and cleared brain tissue, and optogenetics applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Luxendo Boosts InVi SPIM Capabilities for 'Pure Life Imaging'

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
InVi SPIM | Luxendo
Contact: Carolina Araya Callis - Bruker.com 
+49 6221 18731 50 carolina.araya[.]bruker.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Withings BodyScan 2 Now Available in the US - Setting a Standard in Preventive Health and Longevity Monitoring
Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model
Bruker Launches D8 ADVANCE HE and D8 DISCOVER HE High-Energy XRD Systems for Batteries, Amorphous Materials, and Catalysts
Withings Acquires Biosency and Enters Respiratory Remote Monitoring
Bruker Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
Institut Curie, the CEA and Thales Sign a Partnership to Build a Unique FLASH Radiotherapy Platform to Accelerate the Cure for Cancers
Royal Healthcare in Singapore Provides NEC's 'FonesVisuas Test' for Disease Risk Prediction
Bruker Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets At Analytica 2026
Bruker Showcases Extended Automation in Biophysics SLAS2026
SCHOTT Pharma Polymer Cartridge Platform Compatible with Large-volume SHL Medical Autoinjectors
OctoNerv Announces Completion of the First Functional Prototype of the Electronic Breast Nipple Implant (EBNI)
Birmingham’s National NMR Hub Advances UK Biomolecular and Solid-State Research with World-Leading NMR Technology
Bruker Launches The VERTEX NEO Ultra
Bruker Launches xView Module for Ultima 2Pplus Multiphoton Microscopes
LANXESS Presents its Disinfection Portfolio for the First Time At Medica 2025

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit BizJobs.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)